title   
  

Gastrointestinal hormones and roux-en-y gastric bypass

Warning The system is temporarily closed to updates for reporting purpose.

Atalayer, Deniz (2016) Gastrointestinal hormones and roux-en-y gastric bypass. In: Montgomery, Eugene, (ed.) Gastric Bypass Surgery: Procedures, Benefits and Health Risks. Nova Science Publishers, New York, pp. 1-48. ISBN 978-1-63485-412-2 (Print) 978-1-63485-433-7 (Online)

[img]PDF - Registered users only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3471Kb

Abstract

Obesity is a multifactorial global epidemic with associated risk factors for an array of vascular, metabolic, psychological and economical consequences. Bariatric surgery offers the most effective results and Roux-en- Y gastric bypass (RYGB) is the most commonly performed bariatric surgery worldwide. The effective weight loss achieved by RYGB is thought to be caused by the re-arrangement of the gastrointestinal tract leading malabsorption and restriction of the ingested nutrients, and consequently resulting in alterations in the gut hormone levels. This review briefly summarizes the current literature on the changes in the gastrointestinal hormones following RYGB. Understanding these post-operative alterations may provide insights on the efficacy of RYGB that may help developing superior surgical techniques, novel pharmacological and psychological interventions, as well as prevention strategies against obesity.

Item Type:Book Section / Chapter
Subjects:R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
R Medicine > RC Internal medicine
ID Code:30579
Deposited By:Deniz Atalayer
Deposited On:12 Nov 2016 19:08
Last Modified:24 Dec 2018 22:33

Repository Staff Only: item control page